
Godfrey previously served as Head of Medical for Respiratory and Immunology for AstraZeneca UK

Pompe disease is a rare, progressive neuromuscular disease, with infantile onset being the most aggressive form

SPMS is a debilitating stage of MS where patients experience increasing levels of disability

Fontoura previously held senior leadership roles at Xaira Therapeutics and Roche

It is the first anticancer treatment in the UK and globally to be administered this way and a first in multiple myeloma

The treatment can be used to delay the onset of clinical type 1 diabetes

The insulin is designed as an alternative to daily basal insulin

The elected employee representatives will join the Board of Directors after the annual general meeting on 26 March 2026

Construction is expected to be completed in phases from the end of 2027 into 2028

The companies aim to develop next-generation oral medicines for obesity and diabetes

The reduction in price to $675 will take effect at the beginning of next year

There are currently no approved treatments for the neurological symptoms of this disease